NCT05551013View on ClinicalTrials.gov

Treatment of Recurrent GBM With APG-157 Via Expanded Access

NO_LONGER_AVAILABLEEXPANDED_ACCESS

Timeline

Start Date

Not specified

Conditions

GlioblastomaGlioblastoma Multiforme

Interventions

DRUG

APG-157

"APG-157 is an orally administered drug encased in a hydrogel pastille.~Arms:~* Ongoing Stupp protocol (will receive concurrent TMZ + APG-157)~* Progression post TMZ (will receive APG-157 only)~* Ongoing Optune (will receive concurrent Optune + APG-157)~* Progression post Optune (will receive APG-157 only)"